Go Pro
NASDAQ:OM

Outset Medical (OM) Stock Price, News & Analysis

Outset Medical logo
$3.00 -0.03 (-0.99%)
Closing price 04:00 PM Eastern
Extended Trading
$3.00 0.00 (-0.17%)
As of 05:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Outset Medical Stock (NASDAQ:OM)

Advanced

Key Stats

Today's Range
$2.98
▼
$3.09
50-Day Range
$2.96
▼
$5.22
52-Week Range
$2.84
▼
$16.16
Volume
92,503 shs
Average Volume
135,977 shs
Market Capitalization
$56.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.00
Consensus Rating
Hold

Company Overview

Outset Medical, Inc. is a medical technology company focused on simplifying hemodialysis for patients and healthcare providers. The company’s principal product is the Tablo Hemodialysis System, an integrated dialysis platform designed to combine water purification, dialysate production, treatment monitoring and data connectivity in a single device.

Tablo is intended for use in hospitals, outpatient clinics and other care settings, and has also been cleared for home hemodialysis in the United States. The system is designed to reduce the infrastructure, specialized equipment and staff requirements traditionally associated with dialysis, potentially supporting more flexible treatment models. Outset also offers related products and services, including consumables, accessories, software and technical support.

Founded in 2003 and headquartered in San Jose, California, Outset Medical received U.S. Food and Drug Administration clearance for the Tablo system in 2018 and became a publicly traded company on the Nasdaq under the symbol OM in 2020. Its primary commercial focus has been the United States, where it serves acute-care hospitals, dialysis providers and home-care markets.

AI Generated. May Contain Errors.

Outset Medical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
60th Percentile Overall Score

OM MarketRank™: 

Outset Medical scored higher than 60% of companies evaluated by MarketBeat, and ranked 343rd out of 891 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Outset Medical has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on no strong buy ratings, 3 buy ratings, 1 hold rating, and 1 sell rating.

  • Upside Potential

    Outset Medical has a consensus price target of $10.00, representing about 233.3% upside from its current price of $3.00.

  • Amount of Analyst Coverage

    Outset Medical has only been the subject of 1 research reports in the past 90 days.

  • Read more about Outset Medical's stock forecast and price target.
  • Earnings Growth

    Earnings for Outset Medical are expected to grow in the coming year, from ($3.81) to ($3.01) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Outset Medical is -0.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Outset Medical is -0.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Outset Medical has a P/B Ratio of 0.43. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Outset Medical's valuation and earnings.
  • Percentage of Shares Shorted

    4.85% of the float of Outset Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Outset Medical has a short interest ratio ("days to cover") of 6.18.
  • Change versus previous month

    Short interest in Outset Medical has recently decreased by 1.34%, indicating that investor sentiment is improving.
  • Dividend Yield

    Outset Medical does not currently pay a dividend.

  • Dividend Growth

    Outset Medical does not have a long track record of dividend growth.

  • News Sentiment

    Outset Medical has a news sentiment score of 0.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.73 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Outset Medical this week, compared to 2 articles on an average week.
  • MarketBeat Follows

    1 people have added Outset Medical to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Outset Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $46,587.00 in company stock.

  • Percentage Held by Insiders

    2.50% of the stock of Outset Medical is held by insiders.

  • Percentage Held by Institutions

    Outset Medical has minimal institutional ownership at this time.

  • Read more about Outset Medical's insider trading history.
Receive OM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Outset Medical and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

OM Stock News Headlines

Trump goes "all-in" on Grand Canyon energy breakthrough
A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of Saudi Arabia's largest oil field, with potential to last two million years. While the One Big Beautiful Bill Act eliminated federal credits for solar, wind, and EVs, this energy source was reclassified alongside oil and nuclear power and given eight years of tax credits. Google signed a 15-year contract, and Bill Gates committed $100 million. One company controls the entire supply chain behind this discovery.tc pixel
Outset Medical (OM) Q2 2026 Earnings Call Transcript
Stifel Nicolaus Keeps Their Buy Rating on Outset Medical (OM)
Outset Medical (OM) Stock Falls on Q2 2026 Earnings
See More Headlines

OM Stock Analysis - Frequently Asked Questions

Outset Medical's stock was trading at $3.71 on January 1st, 2026. Since then, OM stock has decreased by 19.1% and is now trading at $3.00.

Outset Medical, Inc. (NASDAQ:OM) announced its earnings results on Thursday, August, 6th. The company reported ($0.80) EPS for the quarter, missing analysts' consensus estimates of ($0.72) by $0.08. The company earned $31.64 million during the quarter, compared to the consensus estimate of $28.97 million. Outset Medical had a negative net margin of 63.06% and a negative trailing twelve-month return on equity of 61.67%.
Read the conference call transcript
.

Outset Medical's stock reverse split before market open on Thursday, March 20th 2025.The 1-15 reverse split was announced on Tuesday, March 18th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, March 19th 2025. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Outset Medical (OM) raised $175 million in an initial public offering (IPO) on Tuesday, September 15th 2020. The company issued 7,600,000 shares at a price of $22.00-$24.00 per share. BofA Securities, Morgan Stanley and Goldman Sachs served as the underwriters for the IPO and SVB Leerink and Stifel were co-managers.

Shares of OM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Outset Medical investors own include Pinterest (PINS), Trade Desk (TTD), Fiverr International (FVRR), Teladoc Health (TDOC), Lemonade (LMND) and

Company Calendar

Last Earnings
8/06/2026
Today
9/30/2026
Next Earnings (Estimated)
11/09/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:OM
CIK
1484612
Fax
N/A
Employees
310
Year Founded
2003

Price Target and Rating

High Price Target
$15.00
Low Price Target
$7.00
Potential Upside/Downside
+233.3%
Consensus Rating
Hold
Rating Score (0-4)
2.40
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
($4.09)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$81.65 million
Net Margins
-63.06%
Pretax Margin
-62.27%
Return on Equity
-61.67%
Return on Assets
-28.25%

Debt

Debt-to-Equity Ratio
1.03
Current Ratio
5.19
Quick Ratio
4.11

Sales & Book Value

Annual Sales
$119.48 million
Price / Sales
0.47
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$6.99 per share
Price / Book
0.43

Miscellaneous

Outstanding Shares
18,800,000
Free Float
18,327,000
Market Cap
$56.40 million
Optionable
Not Optionable
Beta
1.90

Social Links

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

This page (NASDAQ:OM) was last updated on 9/30/2026 by MarketBeat.com Staff.
From Our Partners